Navigation Links
Scientists Explore ‘muscle’ in a New Drug to Assuage Muscular Dystrophy Symptos

Muscular dystrophy is a debilitating cluster of genetic disorders that weaken the muscles to such an extent, ultimately crushing the victim’s mobility. The disorder// hampers the victim’s quality of life, while also reducing the lifespan.

Unfortunately, the cure for this disorder still remains a burning ambition for many scientists. Duchenne Muscular Dystrophy or DMD is the most notorious of muscular dystrophy disorders. Sadly, almost 100 male children are born with this crippling disorder each year.

An experimental drug has raised scientists’ hope in being able to repair the genetic aberration, so typical among victims of Duchenne Muscular Dystrophy. The drug PTC124 proved its mettle in repairing the lost muscle function during experiments conducted on rodents. Human trial for this drug is underway, though it might take a while before the results are out.

The drug sets about the repair process by enabling cells to decipher anomalies in the genetic code pertaining to a specific protein called dystrophin. This protein is absent in 15% of patients suffering Duchenne Muscular Dystrophy. In mice, the drug assisted in superseding the mutation in the dystrophin gene, which obstructs the production of the protein.

Expressing optimism over the potential of the new drug, lead researcher Dr H Lee Sweeney said, "This new class of treatment has the potential to help a large number of patients with different genetic diseases that have the same type of mutation."

Dr Marita Pohlschmidt, director of research at the Muscular Dystrophy Campaign, extremely happy with the results of this drug said, “This drug appears to have the potential to become a treatment in the longer term for some people with DMD. We look forward to the publication of the full results of these clinical trials so that we can see more clearly what the prospects and possible timescales are for treatment.”
SV/V
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... serving the families and businesses of the Norwalk and Vermillion areas, celebrates ... Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer ...
(Date:3/23/2017)... ... 23, 2017 , ... The StayWell Company announced today that ... covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, ... excellent programs for the delivery and improvement of disease management and that meet ...
(Date:3/23/2017)... ... ... The TouchPoint Solution, home of Buzzies *, is boosting the Arizona economy ... change the way we interact with stress and live our day-to-day lives,” said Dr. ... December 2016, The TouchPoint Solution has sold more than $750,000 in product sales. The ...
(Date:3/23/2017)... ... 23, 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) from ... pillow in crowdfunding history, has established a U.S. Headquarters in New York City, ... Americans. , “We’re excited to be operating on U.S. shores, where most of our ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017  Interpace Diagnostics Group, Inc. ... fully integrated commercial company that provides clinically useful ... that it has entered into agreements to successfully ... Shareholders ("RedPath") and concurrently terminate its royalty and ... secured debt to RedPath amounting to $9.34 million ...
(Date:3/23/2017)... DENVER , March 23, 2017  Drug ... pain medication misuse and deadly overdoses. A new ... Health Solutions, www.cordantsolutions.com , reports more detailed ... tests, which can potentially improve therapy adherence, patient ... The Cordant Comprehensive Oral fluid Rx Evaluation ...
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD announces that AB Laboratories ... in its licensed production facility under the Access to ... Hamilton, Ontario . The ... in October 2016, is currently operating at half capacity, ...
Breaking Medicine Technology: